FORSTEO
TERIPARATIDE · by ELI LILLY
Composition
Inj: Per ml: Teriparatide 250 mcg; 3 ml pre-filled pen for 28 doses.
Indications & Dosage
Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures, Treatment of corticosteroid-induced osteoporosis: BY SC INJ: Adult: 20 mcg daily for max. duration of treatment 24 months (course not to be repeated).
Administration
Administer by SC inj into the thigh or abdominal wall.
Stability
Store at 2C-8C. Do not freeze. Protect from light. Discard pen 28 days after 1st injection. Do not use if solution is cloudy coloured or contains solid particles.
Contraindications
: Bone metastases, hyperparathyroidism metabolic bone diseases, Pagets disease, pre-existing hypercalcaemia, previous radiation, therapy to the skeleton, skeletal malignancies, unexplained raised alkaline phosphatase
Precautions
Moderate renal impairment (avoid if severe).
Pregnancy
Contraindicated
Lactation
Contraindicated
Side Effects
Anaemia, arthralgia, asthenia, depression, dizziness, dyspnea, fatigue, GI disorders, haemorrhoids, headache, increased sweating, muscle cramps, myalgia, nausea, palpitation, reflux, sciatica, vertigo, hypercalcaemia, injection-site reactions, urinary disorders. Rare: Hypersensitivity reactions